Methods in Pharmacoepidemiology / Measurement Methods

((B-210)) (B-210) Acetaminophen Use During Pregnancy and the Risk of Childhood Attention-Deficit/Hyperactivity Disorder (ADHD): A Quantitative Bias Analysis

((B-211)) (B-211) Evaluation of a pregnancy algorithm using multiple data sources

((B-212)) (B-212) Adaptive multi-wave sampling for efficient chart validation

((B-213)) (B-213) Integrating the Patient Perspective Within Real-World Evidence: A Case Study Linking Routinely Collected Patient-Reported Outcomes and Electronic Health Records from Mass General Brigham Healthcare System

((B-214)) (B-214) Assessing the Incidence of Major Adverse Cardiovascular Events in Medicare Data during the COVID-19 Pandemic

((B-215)) (B-215) Assessing the Risk of Hormonal Contraceptive Failure in the Presence of Drug-Drug Interactions with CYP3A4 inducers

((B-216)) (B-216) A Validation Study to Evaluate Code Based Definitions for Sickle Cell Disease, Genotypes, and Acute and Chronic Complications Using US Optum Electronic Health Records

((B-217)) (B-217) Development and validation of the knowledge, attitude, and practice questionnaire for tuberculosis patients with type II diabetes mellitus: A study from India

((B-218)) (B-218) The Inclusion of Dietary Data in Real-World Gastroenterology Studies: Insights from a Literature Review on Crohn’s Disease

((B-219)) (B-219) Estimating Health Care Contact Days for Medicare Beneficiaries Diagnosed with Metastatic Breast, Colorectal, Lung or Prostate Cancer, 2008-2019

((B-220)) (B-220) Inverse probability weighting to adjust for informative censoring when estimating Desirability of Outcome Ranking (DOOR) probabilities

((B-221)) (B-221) Development and Validation of Identification Algorithms for Five Autoimmune Diseases Using Electronic Health Records: A Retrospective Cohort Study in China

((B-222)) (B-222) Comparison of time-to-next treatment and time-to-event endpoints using real-world data in checkpoint inhibitor-treated patients with advanced non-small cell lung cancer

((B-223)) (B-223) Challenges and Learnings from a Prescription Sequence Symmetry Analysis Replication Study to Inform a Reusable Negative Control Programming Tool

((B-224)) (B-224) Towards Optimizing Identification of First Line of Therapy (LOT) for Metastatic Lung, Breast and Colorectal Cancer in Real World Data: A Scoping Review

((B-225)) (B-225) Utility of Restricted Mean Duration of Response as an Intermediate Outcome in Advanced Non-small Cell Lung Cancer

((B-226)) (B-226) Characterization of Confounding Covariate Data Capture in the U.S. Food and Drug Administration’s Sentinel Distributed Database

((B-227)) (B-227) The Impact of COPD Severity Misclassification on Patients with Different Comorbidities Using a Validated Process: A Nationwide Cohort Study

((B-228)) (B-228) Evaluation of Database-Derived Real-World Disease-Free Survival (rwDFS) in Resected Non-Small Cell Lung Cancer (NSCLC)

((B-229)) (B-229) Validation of Diagnostic Codes for Identifying Chlamydial Infections from TriNetX Electronic Health Record Data in the United States

((B-230)) (B-230) Optimizing the Identification and Classification of Non-Small Cell Lung Cancer (NSCLC): Validation and Implementation of a Patient Cohort Algorithm in Claims Databases